US Patent Issued to Bristol-Myers Squibb on Dec. 2 for "Imidazo[1,2-Apyridine and [1,2,4triazolo[1,5-Apyridine derivatives as TLR9 inhibitors for the treatment of fibrosis" (Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,267, issued on Dec. 2, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Imidazo[1,2-Apyridine and [1,2,4triazolo[1,5-Apyridine derivatives as TLR9 inhibitors for the treatment of fibrosis" was invented by David S. Yoon (Ambler, Pa.), Alicia Regueiro-Ren (New Hope, Pa.), Andrew P. Degnan (Jamison, Pa.) and Gang Wu (Princeton, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to imidazo[1,2-a]pyridine and [1,2,4]triazolo[1, 5-a]pyridine derivatives of formula (I) or a salt thereof. The present compounds are inhibitors of TLR9 and useful in treating preventing, or slowing fibrotic diseases, such as e.g. liver ...